-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

617. Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Poster III

Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis Program: Oral and Poster Abstracts
Type: Poster
Monday, December 7, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Claudia Haferlach, MD, Annette Fasan, PhD*, Manja Meggendorfer, PhD*, Melanie Zenger*, Susanne Schnittger, PhD, Wolfgang Kern, MD and Torsten Haferlach

MLL Munich Leukemia Laboratory, Munich, Germany

Eve Poret1*, Fanny Angelot Delettre1*, Sabeha Biichle2*, Anne Roogy1*, Louis Benazet3*, Maider Pagadoy3*, Chrystelle Vidal3*, Franck Leroux3*, Véronique Harrivel4*, Christophe Ferrand, PhD5, Veronique Salaun6*, Zehaira Benseddik7*, Julien Guy8*, Marie Christine Jacob9*, Christophe Roumier10*, Jean Feuillard11*, Liliana Vila12*, Lucile Baseggio13*, Adriana Plesa14*, Christine Arnoulet15*, B Benet16*, Bernard Drenou, MD17*, Veronique Latger Cannard18*, Marie-Christine Bene, MD19*, Michel Ticchioni20*, Daniel Lusina21*, Valerie Bardet22*, Magalie LE Garff Tavernier23*, Elizabeth Macintyre, MD, PhD24, Vahid Asnafi, MD PhD25*, Maria Elena Noguera23*, Sabrina Bouyer26*, Carine Lecoq Lafon27*, Mikael Roussel, MD, PhD28*, Fabrice Jardin29*, Francoise Solly, MD30*, Lydia Campos, MD, PhD31, Anne Galoisy32*, Anne Arnaud33*, Sylvie Daliphard34*, Franck Genevieve, MD, PhD35*, Romaric Lacroix36*, Françoise Schillinger37*, Estelle Seilles1*, Delphine Binda3*, Eric Deconinck38, Philippe Saas, PhD39 and Francine Garnache Ottou, PhD5*

1EFS BFC, INSERM UMR1098, Besançon cedex, France
2INSERM UMR 1098/Université Bourgogne Franche-Comté/EFS BFC, Besancon, France
3Inserm CIC1431, CHRU de Besançon, Besançon cedex, France
4CHU Amiens, AMIENS, France
5EFS BFC, Inserm UMR1098, University hospital Besancon, University Franche Comte, Besancon, France
6CHU CAEN, CAEN, France
7CH CHARTRES, CHARTRES, France
8CHU DIJON, DIJON, France
9CHU GRENOBLE, GRENOBLE, France
10CHRU LILLE, LILLE, France
11Laboratoire d'hématologie, CHU, Limoges, France
12HOSPITAL LYON EDOUARD HERRIOT, LYON, France
13HOSPITAL LYON SUD, LYON Pierre Benite, France
14HOSPITAL LYON SUD, LYON, France
15IPC, MARSEILLE, France
16CHR METZ, METZ, France
17CH MULHOUSE, MULHOUSE, France
18CHU NANCY, NANCY, France
19Hopital Hotel Dieu, Laboratoire d'Hematologie, Nantes, France
20CHU NICE, NICE, France
21Hematology Laboratory, CHU Avicenne, Paris, France
22Department of Hematology, Imagine Institute, Hôpital Universitaire Necker -Enfants Malades Paris, Paris, France
23APHP, PARIS, France
24Université Paris Descartes Sorbonne Cité, Institut Necker-Enfants Malades (INEM), Institut national de recherche médicale (INSERM) U1151, and Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker Enfants-Malades, Paris, France
25Université Paris Descartes Sorbonne Cité, Institut Necker-Enfants Malades (INEM), Institut national de recherche médicale (INSERM) U1151, and Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker Enfants-Malades, Paris, Paris, France
26CHU POITIERS, POITIERS, France
27CHU REIMS, REIMS, France
28INSERM U917 - CHU de Rennes, Rennes, France
29Centre Henri Becquerel, Rouen, France
30Saint-Etienne University Hospital, Saint-Etienne, France
31Laboratoire Hematologie, Hopital Nord, Saint-Etienne, France
32CHU STRASBOURG, STRASBOURG, France
33CHU NIMES, NIMES, France
34CHU ROUENS, ROUENS, France
35CHU ANGERS, ANGERS, France
36APHM, MARSEILLE, France
37EFSBFC, Besançon cedex, France
38Hematology, INSERM UMR1098 - CHU Jean Minjoz, Besancon, France
39EFS BFC, INSERM UMR 1098/Université Bourgogne Franche-Comté/ EFS BFC/LabEx lispSTIC, Besancon, France

Steven M. Kornblau, MD1, Peter Ruvolo, PhD2, Rui-Yu Wang, MD, PhD1, Vivian Ruvolo, MS3*, Yihua Qiu, MD1*, Venkata Lokesh Battula, PhD4, Zhihong Zeng, MD3, Teresa McQueen2*, Suk-Young Yoo5*, Marina Konopleva, MD, PhD6 and Michael Andreeff, M.D., Ph.D.6

1Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
2Section of Molecular Hematology & Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
4Section of Molecular Hematology and Therapy, Leukemia Department, UT MD Anderson Cancer Center, Houston, TX
5Bioinformatics and Computational Biology, The University of Texas M.D. Anderson Cancer Center, Houston, TX
6Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston

Hidemasa Matsuo, MS1*, Naomi Nakamura, MS1*, Daisuke Tomizawa, MD, PhD2, Akiko M. Saito3*, Nobutaka Kiyokawa, MD, PhD4*, Keizo Horibe, MD, PhD3, Yoko Nishinaka-Arai, PhD5*, Mayu Tokumasu, MD6*, Hiroshi Itoh, MS1*, Yasuhiko Kamikubo, MD, PhD1*, Hideki Nakayama, MD, PhD7*, Akitoshi Kinoshita, MD, PhD8, Takashi Taga, MD, PhD9*, Akio Tawa, MD, PhD10*, Tomohiko Taki, MD, PhD11, Shiro Tanaka, PhD12* and Souichi Adachi, MD, PhD1

1Department of Human Health Sciences, Kyoto University, Kyoto, Japan
2Division of Leukemia and Lymphoma, Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan
3Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
4Department of Pediatric Hematology and Oncology Research, National Research Institute For Child Health and Development, Tokyo, Japan
5Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan
6Department of Pediatrics, Kyoto University, Kyoto, Japan
7Department of Pediatrics, National Hospital Organization, Fukuoka-Higashi Medical Center, Koga, Japan
8Department of Pediatrics, St Marianna University School of Medicine, Kawasaki, Japan
9Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan
10Department of Pediatrics, National Hospital Organization, Osaka National Hospital, Osaka, Japan
11Department of Molecular Diagnostics and Therapeutics, Kyoto Prefectural University of Medicine, Kyoto, Japan
12Department of Pharmacoepidemiology, Kyoto University, Kyoto, Japan

Klaus H. Metzeler, MD1,2,3, Tobias Herold, MD1*, Maja Rothenberg-Thurley, PhD1*, Susanne Amler4*, Cristina Sauerland4*, Stephanie Schneider, PhD1*, Nikola P Konstandin, PhD5*, Annika Maria Dufour, PhD1*, Kathrin Bräundl5*, Bianka Ksienzyk5*, Evelyn Zellmeier5*, Luise Hartmann, MSc2,3,5*, Philipp A. Greif, MD2,3, Michael Fiegl, MD1*, Marion S. Subklewe, MD1,2,3, Stefan K. Bohlander, MD6*, Utz Krug, MD7, Wolfgang E Berdel, MD8, Bernhard J Wörmann, MD9*, Thomas Büchner, MD8*, Andreas Faldum, PhD4*, Wolfgang Hiddemann, MD1,3,10, Jan Braess, MD11* and Karsten Spiekermann, MD1,2,3

1Laboratory for Leukemia Diagnostics, Dept. of Internal Medicine III, University Hospital Großhadern, Ludwig-Maximilians-Universität, Munich, Germany
2German Cancer Consortium (DKTK), Munich, Germany
3German Cancer Research Center (DKFZ), Heidelberg, Germany
4Institute for Biometry and Clinical Research, University of Münster, Münster, Germany
5Department of Internal Medicine III, University Hospital Grosshadern, Ludwig-Maximilians-Universität, Munich, Germany
6Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand
7Klinikum Leverkusen, Leverkusen, Germany
8Department of Medicine A, University of Münster, Münster, Germany
9Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Campus Virchow, Berlin, Germany
10German Cancer Consortium (DKTK), Heidelberg, Germany
11Oncology and Hematology, St. John-of-God Hospital, Regensburg, Germany

Aleksandra Golos, MD, PhD1*, Dorota Jesionek-Kupnicka, Md, PhD2*, Tadeusz Robak, MD, PhD3, Ewa Wawrzyniak, PhD3*, Lidia Anna Gil, MD, PhD4, Mieczyslaw Komarnicki, MD, PhD4, Anna Wache, MD4* and Agnieszka Wierzbowska, MD, PhD1*

1Medical University of Lodz, Department of Hematology, Lodz, Poland
2Medical University of Lodz, Department of Pathology, Lodz, Poland
3Department of Hematology, Medical University of Lodz, Lodz, Poland
4University of Medical Sciences, Department of Hematology, Poznan, Poland

Ekaterina Bulycheva, MD1*, Jiri Mayer2, William Hermann Krüger, MD, PhD3*, Peter Dreger, MD4, Anna Mies1,5*, Zuzana Sustkova, MD6*, Zdenek Racil, MD6*, Jirina Prochazkova, MD6*, Eva Walter, MD7*, Carsten Hirt3*, Mark Ringhoffer, MD8*, Wolfgang E Berdel, MD9, Hubert Serve, MD10*, Christoph Rollig11*, Katja Sockel, MD12*, Martin Bornhäuser, MD13*, Gerhard Ehninger, MD14, Christian Thiede, MD, PhD1,5 and Uwe Platzbecker, MD5,15

1Medical Department I, University Hospital Carl Gustav Carus Dresden, Dresden, Germany
2Department of Internal Medicine - Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
3Department of Internal Medicine C, Hematology and Oncology, Marrow Transplantation, Ernst-Moritz-Arndt-Universität Greifswald, Greifswald, Germany
4Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
5German Cancer Consortium, German Cancer Research Center Heidelberg, Heidelberg, Germany
6Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
7Department of Internal Medicine V, University Hospital of Heidelberg, Heidelberg, Germany
8Department of Internal Medicine III, Municipal Hospital of Karlsruhe, Karlsruhe, Germany
9Department of Medicine A, University Hospital Münster, Muenster, Germany
10Dept. of Internal Medicine, University Hospital of Frankfurt, Frankfurt, Germany
11University Hospital Carl Gustav Carus Dresden, Dresden, Germany
12Medizinische Klinik I, Universitaetsklinikum C.G.Carus, Dresden, Germany
13Department of Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany
14Medical Dept. 1, University Hospital TU Dresden, Dresden, Germany
15Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus, Dresden, Germany

Nikolaus Jahn, MD1*, Mridul Agrawal, MD1*, Lars Bullinger, MD1, Daniela Weber1*, Andrea Corbacioglu, PhD1*, Verena I. Gaidzik, MD1*, Felicitas Thol, MD2, Michael Heuser, MD2, Juergen Krauter, MD3*, Gudrun Göhring4, Andrea Kuendgen, MD5*, Walter Fiedler, MD6, Mohammad Amen Wattad, MD7, Gerhard Held, MD8*, Doris Kraemer, MD9*, Heinz A. Horst, MD, PhD10, Michael Lübbert, MD, PhD11, Arnold Ganser, M.D.2, Richard F. Schlenk, MD12, Hartmut Dohner, MD1, Konstanze Dohner, M.D.12 and Peter Paschka, MD1

1Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
2Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
3Department of Hematology and Oncology, Braunschweig Hospital, Braunschweig, Germany
4Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany
5Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany
6Department of Hematology and Oncology, University Hospital Eppendorf, Hamburg, Germany
7Department of Hematology, Oncology and Stem Cell Transplantation, Kliniken Essen Sued, Essen, Germany
8Department of Internal Medicine I, University Hospital of Saarland, Homburg, Germany
9Department of Oncology and Hematology, Klinikum Oldenburg, Oldenburg, Germany
10Department of Internal Medicine II, University Hospital Schleswig Holstein, Campus Kiel, Kiel, Germany
11Department of Haematology and Oncology, University of Freiburg, Freiburg, Germany
12University Hospital of Ulm, Ulm, Germany

B. Douglas Smith, MD1, Andrew W. Roberts, MBBS, PhD2, Gail J. Roboz, MD3, Mark DeWitte, VMD4, Anna Ferguson, BSN, RN1*, Linda Garrett, RN2*, Tania Curcio5*, Kaysey F. Orlowski6*, Sue Dasen, MS4*, Debra M. Bensen-Kennedy, MD4 and Roland B. Walter, MD, PhD, MS6

1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
2Div. of Cancer and Haem., The Walter & Eliza Hall Institute of Medical Research, Parkville, Australia
3Division of Hematology / Oncology, Weill Cornell Medical College, New York, NY
4CSL Behring, King of Prussia, PA
5Division of Hematology and Medical Oncology, Weill Cornell Medical College/New York Presbyterian Hospital, New York, NY
6Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA

Rose McGlauflin1*, Anna Whitaker1*, Amanda J Favreau1, Christine Duarte1* and Pradeep Sathyanarayana2

1Maine Medical Center Research Institute, Scarborough, ME
2Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough, ME

Manja Meggendorfer, PhD1*, Wolfgang Kern, MD1, Karolína Perglerová2*, Susanne Schnittger, PhD1, Claudia Haferlach, MD1 and Torsten Haferlach1

1MLL Munich Leukemia Laboratory, Munich, Germany
2MLL2 s.r.o., Praha, Czech Republic

Feng-Ming Tien, MD1*, Wen-Chien Chou, MD, PhD2, Hsin-An Hou, MD, PhD1*, Yu-Chiao Chiu3*, Eric Y. Chuang, Sc.D.3*, Chien-Yuan Chen, MD, PhD1*, Jih-Luh Tang, MD, PhD1, Ming Yao, MD1*, Shang-Yi Huang1*, Bor-Sheng Ko4*, Szu-Chun Hsu, MD2*, Shang-Ju Wu, MD, PhD1*, Woei Tsay, MD, PhD1* and Hwei-Fang Tien, MD, PhD1

1Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
2Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan
3Graduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University, Taipei, Taiwan
4National Taiwan University Hospital, Taipei, Taiwan

Jared Wallace1*, Dominique Kagele1*, Ruozhen Hu1*, Marah Runtsch1*, Margaret Alexander1*, Thomas Huffaker1*, Timothy Mosbruger2*, Timothy Dahlem3*, W. Zac Stephens1*, Dinesh S. Rao, MD, PhD4, Rodney R. Miles, MD, PhD5, June Round, PhD1* and Ryan M. O'Connell, PhD1*

1Pathology, University of Utah, Salt Lake City, UT
2Hunstman Cancer Institute, University of Utah, Salt Lake City, UT
3Mutation Generation and Detection Core, University of Utah, Salt Lake City, UT
4UCLA, Los Angeles, CA
5Department of Pathology, University of Utah, Salt Lake City, UT

David K Edwards V, B.A., B.S.1, Angela Rofelty, BS2*, Anupriya Agarwal, PhD2, Stephen E Kurtz, PhD3*, Elie Traer, MD, PhD2, Patrice Lee, PhD4*, David Chantry, PhD4*, Marc Loriaux, MD, PhD2*, Brian J. Druker, MD5, Shannon K. McWeeney, PhD6* and Jeffrey W. Tyner, PhD1

1Knight Cancer Institute, Department of Cell, Developmental & Cancer Biology, Oregon Health and Science University, Portland, OR
2Knight Cancer Institute, Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR
3Knight Cancer Institute, Oregon Health & Science University, Portland, OR
4Array Biopharma, Boulder, CO
5Howard Hughes Medical Institute, Oregon Health & Science University, Knight Cancer Institute, Portland, OR
6Department of Bioinformatics and Computational Biology, Oregon Health & Science University, Portland, OR

Anjali S. Advani, MD1, Paul Elson, PhD2*, Valeria Visconte, PhD3*, Jennifer S. Carew, PhD3, Jaime Fensterl4*, Bartlomiej Przychodzen, MSc3*, Mikkael A. Sekeres, MD, MS1, Cassandra M Hirsch5*, Alek Nielsen6*, John Desamito4*, Hetty E. Carraway, MD, MBA1, Aaron T. Gerds, MD, MS1, Betty K. Hamilton, MD7,8, Sudipto Mukherjee, MD, PhD1, Ronald M. Sobecks, MD7, Matt Kalaycio, MD7, Yogen Saunthararajah, M.D.9 and Jaroslaw P. Maciejewski, MD, PhD10

1Leukemia Program, Cleveland Clinic, Cleveland, OH
2Cleveland Clinic, Quantitative Health Sciences, Cleveland, OH
3Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
4Leukemia Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
5Department of Translational Hematology and Oncology Research, Taussing Cancer Institute, Cleveland Clinic, Cleveland, OH
6Cleveland Clinic, Cleveland
7Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
8Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
9Experimental Hematology and Hematopoiesis Section, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH
10Experimental Hematology and Hematopoiesis Section, Taussig Cancer Center, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Han-Seung Park, MD1*, Je-Hwan Lee, MD, PhD1, Jung-Hee Lee, MD, PhD1*, Dae-Young Kim, MD, PhD2*, Eun-Ji Choi, MD1*, Eun-Hye Hur1*, Chan-Jeoung Park, MD, PhD3, Soseul Kim4*, Sangsoon Yoon4*, Kyeongcheon Jung4* and Kyoo-Hyung Lee, MD, PhD1

1Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
2Department of Hematology, University of Ulsan College of Medicine and Asan Medical Center, Seoul, South Korea
3Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
4Dinona Institute, Dinona Inc., Seoul, South Korea

Grigory Tsaur, MD, PhD1*, Olga Plekhanova2*, Elena Fleischman, MD, PhD3*, Elena Volochnik4*, Olga Sokova, PhD3*, Anatoly Kustanovich, PhD4*, Irina Kalinina, MD, PhD5*, Alexander Popov, MD, PhD1*, Leonid Saveliev, MD, PhD6*, Egor Shorikov, MD, PhD1* and Larisa Fechina, MD, PhD1

1Pediatric Oncology and Hematology, Regional Children's Hospital #1, Research Institute of Medical Cell technolgies, Yekaterinburg, Russia
2Pediatric Oncology and Hematology, Regional Children's Hospital #1, Yekaterinburg, Russia
3N.N. Blokhin Russian Cancer Research Center Russian Academy of Medical Science, Moscow, Russia
4Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus
5D. Rogachev Federal Research Institute of Pediatric Hematology, Oncology and Immunology, Moscow, Russia
6Chair of Laboratory Medicine, Ural State Medical Academy, Research Institute of Medical Cell Technologies, Yekaterinburg, Russia

David Sanford, MD1, Jorge E. Cortes, MD2, Farhad Ravandi, MD1, Wei Qiao3*, Keyur P. Patel, MD, PhD4*, Thuyvan Hoang1, Tapan Kadia, MD1, Hagop M. Kantarjian, MD1 and Gautam Borthakur, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX

Maria Knyrim*, Madlen Jentzsch, MD*, Marius Bill, MD PhD*, Juliane Grimm*, Karoline Schubert*, Michael Cross, PhD*, Georg-Nikolaus Franke, MD*, Wolfram Poenisch, MD*, Vladan Vucinic, MD*, Gerhard Behre, MD*, Dietger Niederwieser, MD and Sebastian Schwind, MD

Hematology and Oncology, University of Leipzig, Leipzig, Germany

Christina Orsmark-Pietras1,2*, Henrik Lilljebjörn1*, Marianne Rissler1*, Vladimir Lazarevic3*, Alexandros Arvanitakis1,3*, Mats Ehinger4*, Gunnar Juliusson, M.D, Ph.D.3 and Thoas Fioretos1,2

1Department of Laboratory Medicine, Division of Clinical Genetics, Lund University, Lund, Sweden
2Department of Clinical Genetics, University and Regional Laboratories Region Skåne, Lund, Sweden
3Department of Hematology, Skåne University Hospital, Lund, Sweden
4Department of Pathology, Skåne University Hospital, Lund, Sweden

Hendrik Folkerts, MSc1*, Bart-Jan A.T.J. Wierenga, PhD2*, Paul J. Coffer, PhD3, Jan Jacob Schuringa, PhD2 and Edo Vellenga, MD, PhD2

1Department of Experimental Hematology, University Medical Center Groningen, Groningen, Netherlands
2Department of Experimental Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University Groningen, Groningen, Netherlands
3Department of Cell Biology, University Utrecht, Utrecht, Netherlands

Jae-Sook Ahn, MD, PhD1*, Hyeoung-Joon Kim, MD, PhD1,2, Yeo-Kyeoung Kim, M.D., Ph.D.1, Seung-Shin Lee, MD1*, Sung-Hoon Jung, MD, PhD3*, Deok-Hwan Yang, MD, PhD1, Je-Jung Lee3, Park Hee Jeong2*, Seung Hyun Choi, PhD2*, Chul Won Jung, MD, PhD4, Jun-Ho Jang, MD, PhD4*, Heeje Kim, MD, PhD5, Joon Ho Moon, M.D., Ph.D.6, Sang Kyun Sohn, MD, PhD6, Sung-Hyun Kim7 and Dennis Dong Hwan Kim, MD, PhD8

1Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, South Korea
2Genomic Research Center for Hematopoietic Diseases, Chonnam National University Hwasun Hospital, Hwasun, South Korea
3Department of Hematology-Oncology,Chonnam National University Hwasun Hospital, Hwasun, South Korea
4Divison of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
5Dept. of Hem./Onc., Catholic HSCT Center, Seoul, South Korea
6Department of Hematology/Oncology, Kyungpook National University Hospital, Daegu, South Korea
7Dong-A University Medical Center, Busan, South Korea
8Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada

Christophe Willekens, MD1*, Angelo Paci2*, Serge Koscielny3*, Alice Marceau4*, Jean-Baptiste Micol, MD5*, Sophie Broutin2*, Cyril Quivoron6*, Véronique Saada2*, Vianney Poinsignon2*, Franck Griscelli2*, Vincent Ribrag, MD7, Cristina Castilla-Llorente5*, Claude Preudhomme4, Virginie Lacronique-Penard6* and Stéphane De Botton5*

1Service d’Hématologie, Gustave Roussy Cancer Center, Villejuif, France
2Département de biologie-pathologie, Institut Gustave Roussy, Villejuif, France
3Service de biostatistiques et épidémiologie, Institut Gustave Roussy, Villejuif, France
4Hematology Laboratory, CHRU Lille, Lille, France
5Gustave Roussy Cancer Center, Villejuif, France
6Inserm U985, Institut Gustave Roussy, Villejuif, France
7Service d'Hématologie, Institut Gustave Roussy, Villejuif, France

Christoph Niemöller1*, Sabine Bleul1*, Nadja Blagitko-Dorfs, PhD1*, Christine Greil, MD1*, Kenichi Yoshida, MD, Ph.D.2*, Rainer Claus, MD1*, Dietmar Pfeifer, PhD1*, Seishi Ogawa, MD, PhD2*, Michael Lübbert, MD1* and Heiko Becker, MD1

1Department of Internal Medicine I, University Freiburg - Medical Center, Freiburg, Germany
2Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

Christophe Willekens, MD1*, Jean-Baptiste Micol, MD2*, Vianney Poinsignon3*, Cyril Quivoron4*, Véronique Saada3*, Sophie Broutin3*, Marie Terroir-Cassou-Mounat5*, David Ghez2*, Jean-Henri Bourhis, MD, PhD2, Jacques Bosq, MD3*, Vincent Ribrag, MD6, Angelo Paci3*, Virginie Lacronique-Penard4* and Stéphane De Botton2*

1Service d’Hématologie, Gustave Roussy Cancer Center, Villejuif, France
2Gustave Roussy Cancer Center, Villejuif, France
3Département de biologie-pathologie, Institut Gustave Roussy, Villejuif, France
4Inserm U985, Institut Gustave Roussy, Villejuif, France
5Département de medecine nucléaire, Institut Gustave Roussy, Villejuif, France
6Service d'Hématologie, Institut Gustave Roussy, Villejuif, France

Sally Agersborg, MD, PhD1*, Maya Thangavelu, PhD1, Wanlong Ma, BS1*, Steven Brodie, Ph.D2*, Christopher Mixon, MD3*, Wayne Chen, MD1* and Maher Albitar1

1NeoGenomics Laboratories, Irvine, CA
2NeoGenomics Laboratories, Ft. Myers, FL
3NeoGenomics Laboratories, Nashville, TN

Giorgia Simonetti, PhD1*, Antonella Padella1*, Ítalo Faria do Valle2*, Gabriele Fontanarosa2*, Elisa Zago, PhD3*, Marianna Garonzi4*, Cristina Papayannidis, MD, PhD5, Maria Chiara Abbenante, MD1*, Giovanni Marconi, MD1*, Viviana Guadagnuolo, PhD1*, Maria Chiara Fontana6*, Samantha Bruno7*, Anna Ferrari, PhD1*, Elisa Zuffa, PhD1*, Eugenia Franchini1*, Annalisa Astolfi, PhD8*, Elisa Dan7*, Barbara Sinigaglia7*, Ilaria Iacobucci, PhD7*, Simona Soverini9, Michele Cavo, MD7*, Emanuela Ottaviani7*, Alberto Ferrarini, PhD4*, Massimo Delledonne, PhD3*, Daniel Remondini, PhD2* and Giovanni Martinelli, MD, PhD5

1University of Bologna, Bologna, Italy
2Department of Physics and Astronomy, University of Bologna, Bologna, Italy
3Personal Genomics, Verona, Italy
4Department of Biotechnology, University of Verona, Verona, Italy
5Bologna University School of Medicine, Bologna, Italy
6"Seràgnoli" Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
7"Seràgnoli" Institute of Hematology, University of Bologna, Bologna, Italy
8Centro Interdipartimentale per la Ricerca sul Cancro “G. Prodi”, University of Bologna, Bologna, Italy
9Institute of Hematology, S.Orsola-Malpighi University Hospital, Bologna, Italy

Anthony Palmer1*, Brian Parkin2, Hidde Posthuma3*, Shin Mineishi, MD4, John M. Magenau5 and Sami N. Malek2

1Pediatrics, University of Michigan, Ann Arbor, MI
2Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI
3University of Michigan, Ann Arbor, MI
4Blood and Marrow Transplantation and Cell Therapy Program, University of Alabama at Birmingham, Birmingham, AL
5Adult Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI

Emilia Carolina Malafaia, MD1,2*, A. Mario Marcondes, MD, PhD3,4, Ekapun Karoopongse, MD3*, Daniele Serehi, BS2*, Maria de Lourdes L. F. Chauffaille, MD, PhD1,2, H. Joachim Deeg, MD3,4 and Daniella M. Bahia Kerbauy, MD, PhD1,2*

1Fleury Medicine and Health, São Paulo, Brazil
2Federal University of Sao Paulo - UNIFESP, São Paulo, Brazil
3Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
4Department of Medicine, University of Washington, Seattle, WA

Giorgia Simonetti, PhD1*, Antonella Padella1*, Ítalo Faria do Valle2*, Marco Manfrini, PhD3*, Cristina Papayannidis, MD, PhD3, Carmen Baldazzi, PhD1*, Maria Chiara Fontana4*, Viviana Guadagnuolo, PhD1*, Anna Ferrari, PhD1*, Elisa Zago, PhD5*, Marianna Garonzi6*, Simona Bernardi7*, Emanuela Ottaviani1*, Annalisa Astolfi, PhD8*, Maria Chiara Abbenante, MD1*, Giovanni Marconi, MD1*, Simona Soverini9, Michele Cavo, MD10*, Nicoletta Testoni1*, Alberto Ferrarini, PhD6*, Massimo Delledonne, PhD5*, Torsten Haferlach11, Daniel Remondini, PhD2*, Ilaria Iacobucci, PhD10* and Giovanni Martinelli10

1University of Bologna, Bologna, Italy
2Department of Physics and Astronomy, University of Bologna, Bologna, Italy
3Bologna University School of Medicine, Bologna, Italy
4"Seràgnoli" Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
5Personal Genomics, Verona, Italy
6Department of Biotechnology, University of Verona, Verona, Italy
7Unit of Blood Diseases and Stem Cells Transplantation, University of Brescia, Brescia, Italy
8Centro Interdipartimentale per la Ricerca sul Cancro “G. Prodi”, University of Bologna, Bologna, Italy
9Institute of Hematology, S.Orsola-Malpighi University Hospital, Bologna, Italy
10"Seràgnoli" Institute of Hematology, University of Bologna, Bologna, Italy
11MLL Munich Leukemia Laboratory, Munich, Germany

Erik Malmberg, MD1*, Sara Ståhlman2*, Anna Rehammar3*, Tore Samuelsson, Professor1*, Sofie J Alm1*, Erik Kristiansson, PhD3*, Jonas Abrahamsson4*, Hege Garelius, MD5*, Lars Palmqvist, MD, PhD1,2 and Linda Fogelstrand, MD, PhD1,2

1Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
2Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden
3Mathematical Sciences, Chalmers University of Technology and University of Gothenburg, Gothenburg, Sweden
4Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
5Department of Medicine, Sect. of Hematology and Coagulation, Sahlgrenska University Hospital, Göteborg, Sweden

Jae-Ho Yoon, M.D.1*, Hee-Je Kim, M.D.1, Byung Sik Cho1*, Seung-Ah Yahng2*, Seung-Hwan Shin3*, Sung-Eun Lee, M.D.1*, Ki-Seong Eom1*, Yoo-Jin Kim, M.D.1, Seok Lee, M.D.1, Chang-Ki Min, M.D.1*, Seok-Goo Cho, M.D.1, Dong-Wook Kim4, Jong-Wook Lee, M.D.1 and Woo-Sung Min, M.D.1*

1Department of Hematology, Catholic Blood and Marrow Transplantation Center, Cancer Research Institute, Seoul St. Mary’s hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea
2Department of Hematology, Catholic BMT Center, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea
3Department of Hematology, Catholic Blood and Marrow Transplantation Center, Cancer Research Institute, Yeoeuido St. Mary’s hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Seoul, South Korea
4Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, South Korea

Martin Neumann, MD1,2*, Sebastian Vosberg, MSc3,4,5*, Eva Kristin Von Der Heide, BSc1*, Cornelia Schlee1*, Jutta Ortiz Tanchez1*, Konstandina Isaakidis1*, Liliana H. Mochmann, BS, MSc1*, Lars R. Fransecky1*, Alexander Graf, PhD6*, Stefan Krebs, PhD6*, Helmut Blum, PhD6*, Philipp A. Greif, MD3,4,7 and Claudia D Baldus, MD1,2

1Department of Hematology and Oncology, Charité University Hospital, Berlin, Germany
2German Cancer Consortium (DKTK), Berlin, Germany
3Department of Internal Medicine III, Ludwig-Maximilians-University, Munich, Germany
4German Cancer Research Center (DKFZ), Heidelberg, Germany
5German Cancer Consortium (DKTK), Heidelberg, Germany
6Laboratory for Functional Genome Analysis, Gene-Center, Ludwig-Maximilians-University, Munich, Germany
7German Cancer Consortium (DKTK), Munich, Germany

Anna Dolnik, PhD1*, Sundaram R. Chakkarappan, PhD1*, Tamara J. Blätte1*, Sibylle Cocciardi1*, Jan Krönke, MD1*, Corbacioglu Andrea, PhD1*, Karlheinz Holzmann, PhD2*, Peter Paschka, MD1, Frank G. Rücker, MD1*, Silke Kapp-Schwoerer, MD1*, Verena I. Gaidzik, MD1*, Richard F. Schlenk, MD1, Hartmut Döhner, Prof. Dr.1, Konstanze Döhner, MD1 and Lars Bullinger, MD1

1Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
2University of Ulm, Genomics Core Facility, Ulm, Germany

Elena Manara, PhD1*, Valeria Bisio, BS2*, Marco Frison, MD2*, Katia Polato2*, Claudia Tregnago, PhD2*, Barbara Buldini, MD2*, Riccardo Masetti, MD3*, Roberto Rondelli, MD4*, Gianni Cazzaniga, PhD5, Andrea Biondi, Prof, MD6, Franco Locatelli, Prof, MD, PhD7*, Martina Pigazzi, PhD2* and Giuseppe Basso, Prof, MD2

1Hematology-Oncology Laboratory, IRP-Istituto di Ricerca Pediatrica-University of Padova, Padova, Italy
2Woman and Child Health Department, University of Padova, Padova, Italy
3Pediatric Oncology and Hematology, University of Bologna, Bologna, Italy
4Sant'Orsola Hospital, University of Bologna, Bologna, Italy
5Department of Pediatrics, Tettamanti Research Center, University of Milano-Bicocca, Fondazione MBBM/San Gerardo Hospital, Monza, Italy
6Centro Ricerca Tettamanti, Clinica Pediatrica, Università Milano Bicocca, Osp. San Gerardo/Fondazione MBBM, Monza (MB), Italy
7Department of Pediatric Hematology and Oncology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy

Simone Weber1*, Manja Meggendorfer, PhD1*, Niroshan Nadarajah, M.Sc.1*, Karolína Perglerová2*, Susanne Schnittger, PhD1, Claudia Haferlach, MD1, Wolfgang Kern, MD1 and Torsten Haferlach1

1MLL Munich Leukemia Laboratory, Munich, Germany
2MLL2 s.r.o., Praha, Czech Republic

Pedro Martin-Cabrera, MD1*, Sabine Jeromin, PhD1*, Tamara Alpermann1*, Karolína Perglerová2*, Claudia Haferlach, MD1, Wolfgang Kern, MD1 and Torsten Haferlach1

1MLL Munich Leukemia Laboratory, Munich, Germany
2MLL2 s.r.o., Praha, Czech Republic

Suzanne Kamel-Reid, PhD, DABMG, FACMG1, Mariam Thomas, PhD2*, Mahadeo A. Sukhai, BSc, MSc, PhD2*, Dwayne L. Barber, PhD3, Swati Garg, PhD2*, Maksym Misyura, PhD2*, Roozbeh Dolatshahi2*, Djamel Harbi2*, Tong Zhang2*, Anna Porwit, MD, PhD4*, Jan M.A. Delabie, MD, PhD4*, Narmin Ibrahimova3*, Mohamed Shanavas, MD, FRACP, FRCPA3, Karen W.L. Yee, MD3, Trevor J. Pugh, PhD5*, Philippe Bedard, MD3*, Aaron D. Schimmer, MD, PhD3, Tracy L. Stockley, PhD2*, Vikas Gupta, MD, FRCP, FRCPath3, Mark D. Minden, MD, PhD3 and Andre C Schuh, MD, FRCPC3

1University Health Network, Molecular Diagnostics, Department of Pathobiology and Laboratory Medicine, Toronto, ON, Canada
2Advanced Molecular Diagnostics Laboratory, University Health Network, Toronto, ON, Canada
3Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
4Department of Pathobiology and Laboratory Medicine, University Health Network, Toronto, ON, Canada
5The Ontario Cancer Institute, University Health Network, Toronto, ON, Canada

Hanna A. Knaus, MD1*, Raúl Montiel-Esparza, MD1*, Joshua F. Zeidner, MD2, Amanda Blackford, ScM1*, Christopher G. Kanakry, MD1, Ante Vulic, MD1*, Mark J. Levis, MD, PhD1, Judith E. Karp, MD1, Leo Luznik, MD1* and Ivana Gojo, MD1

1Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
2Department of Medicine, Division of Hematology/Oncology, University of North Carolina- Lineberger Comprehensive Cancer Center, Chapel Hill, NC

Gevorg Tamamyan, MD, MSc1,2*, Gautam Borthakur, MD2, Jorge E. Cortes, MD3, Farhad Ravandi, MD2, Elias Jabbour2, Naval Daver, MD2, Naveen Pemmaraju, MD2, Maro Ohanian, DO2*, Albert Kolomansky, MD2*, Gabriele Todisco, MD2*, Ce Shi, MD, PhD2,4*, Sherry Pierce, BSN, BA2*, S. Andrew Peng, MS5*, Marina Konopleva, MD, PhD2, Hagop M. Kantarjian, MD2 and Tapan Kadia, MD3

1Department of Oncology, Yerevan State Medical University, Yerevan, Armenia
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Leukemia, First Affiliated Hospital, Harbin Medical University, Harbin, China
5Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX

Pamela S. Becker, MD, PhD1,2, Michael W. Schmitt, MD, PhD3*, Zhiyi Xie, PhD4*, Andrew Carson, PhD5*, Bradley Patay, MD5*, Seyed Sina Khankhajeh6*, Qi Wei7*, Ling-Hong Hung7*, Timothy Martins, PhD8*, Elihu H. Estey, MD1*, C. Anthony Blau, MD9,10*, Vivian G. Oehler, MD10 and Ka Yee Yeung, PhD7*

1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
2Division of Hematology and Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA
3Hematology and Medical Oncology, University of Washington, Seattle, WA
4Invivoscribe, San Diego, CA
5Genection, San Diego, CA
6Institute of Technology, University of Washington, Tacoma, Tacoma, WA
7Institute of Technology, University of Washington, Tacoma, Tacoma, WA
8Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA
9Center for Cancer Innovation, University of Washington, Seattle, WA
10Division of Hematology, University of Washington, Seattle, WA

Maxim Norkin, MD, PhD1, Myron Chang, PhD2*, An Qi, PhD3*, Helen Leather, BPharm1, Lakshmikanth Katragadda, MD1, Ying Li, MD, PhD4*, Jan S Moreb, MD1, W. Stratford May, MD, PhD1, Randy A. Brown, MD1, Jack W. Hsu, MD1, John W Hiemenz, MD1*, John R Wingard, MD1* and Christopher R. Cogle, MD1

1University of Florida, Gainesville, FL
2Department of Biostatistics, College of Medicine, University of Florida, Gainesville, FL
3University of Florida, College of Medicine, Department of Biostatistics, Gainesville, FL
4Pathology, Immunoolgy and Laboratory Medicine, University of Florida, Gainesville, FL

Yuan Li, M.D.1*, Ming Yue, Ph.D.1*, John Anastasi, MD2, Jeffery Q Shen, Ph.D.3*, Yali Dou, Ph.D.4*, Richard A. Larson, MD5, James W. Vardiman, MD2 and Jason X. Cheng, MD, PhD2

1University of Chicago, Chicago
2Department of Pathology, University of Chicago, Chicago, IL
3Bioinformatics Core, University of Nevada, Las Vegas, Las Vegas
4University of Michigan, Ann Arbor, MI
5Medicine, University of Chicago, Chicago, IL

Amy E Knight Johnson, MS1*, Lucia Guidugli, PhD1*, Kelly Arndt, BA1*, Gorka Alkorta-Aranburu, PhD1*, Viswateja Nelakuditi, MS1*, Jane E. Churpek, MD2, Lucy A Godley, MD, PhD3, Daniela del Gaudio, PhD1*, Soma Das, PhD1* and Zejuan Li, MD, PhD1

1Human Genetics, University of Chicago, Chicago, IL
2Department of Medicine, Section of Hematology/Oncology, The University of Chicago Medicine, Chicago, IL
3Department of Medicine, Section of Hematology-Oncology, University of Chicago Medical Center, Chicago, IL

Arhamatoulaye Maiga, Ph.D.1*, Sébastien Lemieux, Ph.D.1,2*, Caroline Pabst, M.D.1*, Vincent-Philippe Lavallée, M.D.1,3*, Michel Bouvier, Ph.D.1,4*, Guy Sauvageau, M.D., Ph.D.1,3,5,6 and Josée Hébert, M.D.1,3,5,6

1The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada
2Department of Computer Science and Operations Research, Université de Montréal, Montréal, QC, Canada
3Hematology-Oncology Division, Maisonneuve-Rosemont Hospital, Montréal, QC, Canada
4Department of Biochemistry, Université de Montréal, Montréal, QC, Canada
5Quebec Leukemia Cell Bank, Maisonneuve-Rosemont Hospital, Montréal, QC, Canada
6Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada

Shinya Sato, MD, PhD1*, Yasushi Miyazaki, MD, Ph.D.2, Hidehiro Itonaga, MD, PhD3*, Masataka Taguchi, MD3*, Yasushi Sawayama, MD, PhD1*, Daisuke Imanishi, MD, PhD4*, Tomoko Hata, MD, PhD1*, Yukiyoshi Moriuchi, MD3*, Hiroyuki Mishima5* and Kohichiro Yoshiura5*

1Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan
2Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan
3Department of Hematology, Sasebo City General Hospital, Sasebo, Japan
4Department of Hematology, Goto Central Hospital, Goto, Japan
5Department of Human Genetics, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

Bijender Kumar, PhD1*, Lei Zhang, PhD.2,3*, Yunan Miao2,3*, Gerald Wuenschell2,3*, Allen Lin4*, Vinod Pullarkat, MD1, Guido Marcucci, MD1*, Robert Hickey, PhD.2,3* and Ching-Cheng Chen, PhD1

1Division of Hematopoietic Stem Cell and Leukemia Research of Beckman Research Institute, Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA
2Department of Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, CA
3Translational Biomarker Discovery Core, Beckman Research Institute of City of Hope, Duarte, CA
4Division of Hematopoietic Stem Cell and Leukemia Research of Beckman Research Institute, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA

Frédéric Barabé, MD1,2, Malika Laouedj3* and Philippe Tessier4*

1Centre de Recherche du CHU de Québec, Centre de Recherche en Infectiologie, Québec, Canada
2Department of Medicine, Université Laval, Québec, Canada
3Centre de recherche en infectiologie, Centre de recherche du CHU de Quebec, Université laval, Faculté de Medecine, Québec, Canada
4Centre de recherche en infectiologie, Centre de recherche du CHU de Québec, Université laval, Faculté de Medecine, Québec, Canada

Sebastian Vosberg, MSc1,2,3*, Luise Hartmann, MSc1,2,3*, Stephanie Schneider, PhD4*, Klaus H. Metzeler, MD1,2,3, Bianka Ksienzyk2*, Kathrin Bräundl1,2,3*, Martin Neumann, MD3,5*, Claudia D Baldus, MD3,5, Alexander Graf, PhD6*, Stefan Krebs, PhD6*, Helmut Blum, PhD6*, Karsten Spiekermann, MD1,2,3, Stefan K. Bohlander, MD7*, Ulrich Mansmann, PhD3,8* and Philipp A. Greif, MD1,2,3

1German Cancer Research Center (DKFZ), Heidelberg, Germany
2Department of Internal Medicine III, University Hospital Grosshadern, Ludwig-Maximilians-Universität, Munich, Germany
3German Cancer Consortium (DKTK), Heidelberg, Germany
4Laboratory for Leukemia Diagnostics, Dept. of Internal Medicine III, University Hospital Großhadern, Ludwig-Maximilians-Universität, Munich, Germany
5Department of Hematology and Oncology, Charité University Hospital, Berlin, Germany
6Laboratory for Functional Genome Analysis, Gene-Center, Ludwig-Maximilians-University, Munich, Germany
7Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand
8Institute for Medical Informatics, Biometry and Epidemiology, Ludwig-Maximilians-University (LMU), Munich, Munich, Germany

Mi-Hyun Bae, MD, PhD1*, Young-Uk Cho, MD, PhD1, Bohyun Kim1*, Dong Hyun Lee1*, Seongsoo Jang, MD, PhD1, Eul-Ju Seo, MD, PhD1*, Chan-Jeoung Park, MD, PhD1, Dae-Young Kim, MD, PhD2, Jung-Hee Lee, MD, PhD3*, Je-Hwan Lee, MD, PhD2, Kyoo-Hyung Lee, MD, PhD2, Yoon Hwan Chang4* and In-Suk Kim5*

1Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, South Korea
2Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
3Department of Hematology, University of Ulsan College of Medicine and Asan Medical Center, Seoul, South Korea
4Department of Laboratory Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, South Korea
5Department of Laboratory Medicine, Pusan National University Yangsan Hospital, Pusan, South Korea

*signifies non-member of ASH